With the end of 2014 almost here, WuXi PharmaTech sent a Christmas greeting that highlights the China CRO/CMO’s accomplishments in biologics, including having built the largest biologics development team of any CRO/CMO. Several years ago, WuXi identified biologics as a major focus for growth, allocating much of its considerable annual capex budget on biologics. As Chris Chen, PhD, Senior Vice President and Chief Technology Officer of WuXi, pointed out in his Christmas email, WuXi has achieved significant biologics milestones as a result.
Help employers find you! Check out all the jobs and post your resume.
